27 key compounds were obtained from two databases, TCMID and TCMSP, 45 intersection targets were obtained using the Venn Diagram, and SRC was identified as the main target of EF in the treatment of liver cancer using network integration analysis. This evidence concerns the gene SRC and liver cancer.